The award demonstrates AstraZeneca Vietnam’s great achievements over nearly three decades of being an attractive workplace for local talent and a trusted partner of Vietnam’s health system and economy.
Nitin Kapoor, chairman and general director of AstraZeneca Vietnam and Asia Area Frontier Markets said, “We are proud that our entrepreneurial, collaborative, and empowering workplace culture is recognised by our employees and the award organisers. Along with our vision to bring life-changing medicines and vaccines to millions of people in Vietnam, we want our team members – our biggest asset – to realise the full breadth of their potential and will continue to build AstraZeneca as the best place to work.”
|Nitin Kapoor, chairman and general director of AstraZeneca Vietnam and Asia Area Frontier Markets, at the award ceremony |
AstraZeneca Vietnam ranks 15th overall, and fourth in the Pharmaceutical, Medical Equipment, and Healthcare Services category, according to the 2022 Vietnam 100 Best Places to Work ranking by Anphabe and market research firm Intage. This year, 515 companies were surveyed.
Currently, AstraZeneca employs over 500 people in Vietnam, many of whom have worked with the company for more than ten, or even 25, years.
AstraZeneca focuses on achieving equality and inclusion. This has been expressed through not only its commitment to broad and equitable access to its vaccine during the pandemic but also through the demographics of its workforce. In Vietnam, more than half of its employees, including the leadership team, are female.
| ||AstraZeneca enhancing sustainability and resilience of healthcare system |
The Health Strategy and Policy Institute (HSPI) under the Ministry of Health and AstraZeneca Vietnam on July 20 signed an MoU to commence the Partnership for the Vietnamese Health System’s Sustainability and Resilience (PHSSR) programme in 2022-2025.
| ||Health financing tops response priorities |
In light of profound pandemic impacts, Vietnam is moving to cooperate with international stakeholders to increase the sustainability and resilience of the health system, with health financing being among the top priorities ahead.
| ||AstraZeneca’s COVID-19 vaccine preventing over 230,000 deaths in Vietnam |
AstraZeneca’s COVID-19 vaccine has been estimated to have prevented 232,766 deaths in Vietnam, according to an independent assessment of vaccine effectiveness conducted by Airfinity.
| ||AstraZeneca to increase early patient access to new medicines in Vietnam |
Last week marked an important step in AstraZeneca’s journey in Vietnam. On his visit to Hanoi, Dr. John L. Perez, senior vice president of the Vaccines and Immune Therapies Unit at AstraZeneca, talked to VIR’s Bich Thuy about the company’s future ambition and ongoing efforts to increase Vietnamese patients’ early access to new medicines.
| ||MoH and AstraZeneca partner on care for non-communicable diseases |
The Medical Services Administration (MSA), under Vietnam’s Ministry of Health (MoH), and AstraZeneca Vietnam signed an MoU on September 20 to partner on the CaReMe – Love Yourself programme for the 2022-2025 period, aiming to enhance the quality of care for cardiovascular, renal, and metabolic diseases.